micro-community-banner
Profile Image
  • Add Media
  • Saved

1yr
Exploring Advances in Psychopharmacology at the NEI Annual Conference

In this video, Dr. David Goodman, an NEI faculty member and Johns Hopkins expert, explores the latest advancements in psychopharmacology presented at the 2024 NEI Annual Conference. Key highlights include the emerging role of GLP-1 receptor agonists in managing diabetes and their potential to address brain inflammation. Dr. Goodman also discusses innovative treatments for ADHD and Alzheimer’s, as well as groundbreaking research into intracellular processes like mTOR pathway modulation. These insights equip physicians with actionable strategies to enhance the precision and efficacy of neurological and psychiatric care.

  • Saved

1yr
Clinically Effective Molecules of Natural Origin for Obesity Prevention or Treatment - PubMed

Clinically Effective Molecules of Natural Origin for Obesity Prevention or Treatment - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38473918/

The prevalence and incidence of obesity and the comorbidities linked to it are increasing worldwide. Current therapies for obesity and associated pathologies have proven to cause a broad number of...

Natural bioactive compounds, including curcumin, resveratrol, and probiotics, show promise for obesity management by influencing metabolism, reducing inflammation, and improving insulin sensitivity, offering affordable alternatives to conventional obesity therapies.

Profile Image
  • Saved

1yr
Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation‑mediating treatment options (Review) - PubMed

Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation‑mediating treatment options (Review) - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38606791/

Obesity reaches up to epidemic proportions globally and increases the risk for a wide spectrum of co‑morbidities, including type‑2 diabetes mellitus (T2DM), hypertension, dyslipidemia, cardiovascular diseases, non‑alcoholic fatty liver disease,...

Obesity triggers systemic low-grade inflammation via pro-inflammatory macrophages in adipose tissue, leading to metabolic syndrome and insulin resistance. Anti-inflammatory agents may offer therapeutic potential but require further clinical validation.

Profile Image
  • Saved

1yr
What causes obesity in children and adolescents? - PubMed

What causes obesity in children and adolescents? - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/37918812/

The causal factors described in the scientific literature that have been shown to be related to obesity in childhood and adolescence are presented.

This review highlights key biopsychosocial factors contributing to obesity in children and adolescents, analyzing risks across six developmental stages, and summarizing causal factors from pre-conception to adolescence.

Profile Image
  • Saved

1yr
The Role of Obesity in Type 2 Diabetes Mellitus-An Overview - PubMed

The Role of Obesity in Type 2 Diabetes Mellitus-An Overview - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38339160/

Obesity or excessive weight gain is identified as the most important and significant risk factor in the development and progression of type 2 diabetes mellitus (DM) in all age groups....

Obesity is a key risk factor for type 2 diabetes, with weight loss improving blood glucose control. A combined approach of diet, exercise, and lifestyle modifications is crucial for prevention and management.

Profile Image